首页 > 最新文献

Journal of the American Pharmacists Association最新文献

英文 中文
When pharmacist becomes patient 当药剂师变成病人。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-21 DOI: 10.1016/j.japh.2026.103028
Jordan R. Covvey
{"title":"When pharmacist becomes patient","authors":"Jordan R. Covvey","doi":"10.1016/j.japh.2026.103028","DOIUrl":"10.1016/j.japh.2026.103028","url":null,"abstract":"","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 2","pages":"Article 103028"},"PeriodicalIF":2.5,"publicationDate":"2026-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146042199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why do sleep disorders remain undermanaged? Insights from pharmacists and physicians using the COM-B framework 为什么睡眠障碍仍未得到有效管理?药剂师和医生使用COM-B框架的见解。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-20 DOI: 10.1016/j.japh.2026.103026
Raya Aljobowry, Lujain Aloum, Amna M. Othman, Elizabeth Manias, Rana M. Ibrahim, Safa Ziad Alawad, Hamzah Alzubaidi

Background

There is limited understanding of how community pharmacists and physicians support sleep health management in Arabic-speaking countries.

Objectives

This study aims to utilize the Capability, Opportunity, Motivation-Behavior (COM-B) model to explore the perspectives and practices of pharmacists and physicians in addressing sleep health issues and identify the drivers and barriers influencing these practices.

Methods

Semi-structured individual interviews were conducted with a purposive sample of pharmacists and physicians in the United Arab Emirates. Interview guides were developed based on the COM-B framework. All interviews were audio-recorded and transcribed verbatim. Data were coded using NVivo software Version 14 (formerly QSR International) and analyzed deductively based on the theoretical framework.

Results

A total of 45 health care providers (29 pharmacists and 16 physicians) were interviewed. Participants perceived sleep-related concerns in the general population to be insufficiently addressed. Shared barriers to addressing sleep concerns included limited time, lack of knowledge, and formal training, and stigma surrounding sleep. Pharmacists referred chronic cases to physicians and dispensed sedating antihistamines or herbal products to acute cases and were hindered by the lack of private counseling areas and limited therapeutic options. Physicians were reluctant to prescribe medications due to possible dependency and insurance concerns. Both provider groups recognized the importance of sleep to overall health and expressed motivation to help their patients.

Conclusions

This study provides shared and profession-specific barriers and enablers that shape sleep health care provision practices of pharmacists and physicians in the region. It provides avenues for targeted interventions to improve sleep health care delivery in primary care and community settings.
背景:关于阿拉伯语国家社区药剂师和医生如何支持睡眠健康管理的了解有限。本研究旨在运用能力-机会-动机-行为(COM-B)模型,探讨药师和医生在解决睡眠健康问题方面的观点和实践,并找出影响这些实践的驱动因素和障碍。方法:对阿拉伯联合酋长国的药剂师和医生进行半结构化的个人访谈。访谈指南是根据COM-B框架编制的。所有采访都有录音记录,并逐字抄写。使用NVivo软件版本14对数据进行编码,并根据理论框架进行演绎分析。结果:共访谈45名医疗服务提供者(药师29名,医师16名)。参与者认为,一般人群中与睡眠有关的问题没有得到充分解决。解决睡眠问题的共同障碍包括时间有限,缺乏知识和正规培训,以及围绕睡眠的耻辱。药剂师将慢性病例转介给医生,并为急性病例配发镇静抗组胺药或草药产品,但由于缺乏私人咨询领域和有限的治疗选择而受到阻碍。由于可能的依赖性和保险方面的考虑,医生不愿意开药物。两组提供者都认识到睡眠对整体健康的重要性,并表达了帮助患者的动机。结论:本研究提供了共同的和专业特定的障碍和促进因素,形成了该地区药剂师和医生的睡眠卫生保健提供实践。它为有针对性的干预措施提供了途径,以改善初级保健和社区环境中的睡眠卫生保健服务。
{"title":"Why do sleep disorders remain undermanaged? Insights from pharmacists and physicians using the COM-B framework","authors":"Raya Aljobowry,&nbsp;Lujain Aloum,&nbsp;Amna M. Othman,&nbsp;Elizabeth Manias,&nbsp;Rana M. Ibrahim,&nbsp;Safa Ziad Alawad,&nbsp;Hamzah Alzubaidi","doi":"10.1016/j.japh.2026.103026","DOIUrl":"10.1016/j.japh.2026.103026","url":null,"abstract":"<div><h3>Background</h3><div>There is limited understanding of how community pharmacists and physicians support sleep health management in Arabic-speaking countries.</div></div><div><h3>Objectives</h3><div>This study aims to utilize the Capability, Opportunity, Motivation-Behavior (COM-B) model to explore the perspectives and practices of pharmacists and physicians in addressing sleep health issues and identify the drivers and barriers influencing these practices.</div></div><div><h3>Methods</h3><div>Semi-structured individual interviews were conducted with a purposive sample of pharmacists and physicians in the United Arab Emirates. Interview guides were developed based on the COM-B framework. All interviews were audio-recorded and transcribed verbatim. Data were coded using NVivo software Version 14 (formerly QSR International) and analyzed deductively based on the theoretical framework.</div></div><div><h3>Results</h3><div>A total of 45 health care providers (29 pharmacists and 16 physicians) were interviewed. Participants perceived sleep-related concerns in the general population to be insufficiently addressed. Shared barriers to addressing sleep concerns included limited time, lack of knowledge, and formal training, and stigma surrounding sleep. Pharmacists referred chronic cases to physicians and dispensed sedating antihistamines or herbal products to acute cases and were hindered by the lack of private counseling areas and limited therapeutic options. Physicians were reluctant to prescribe medications due to possible dependency and insurance concerns. Both provider groups recognized the importance of sleep to overall health and expressed motivation to help their patients.</div></div><div><h3>Conclusions</h3><div>This study provides shared and profession-specific barriers and enablers that shape sleep health care provision practices of pharmacists and physicians in the region. It provides avenues for targeted interventions to improve sleep health care delivery in primary care and community settings.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 2","pages":"Article 103026"},"PeriodicalIF":2.5,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146032580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the APhA Foundation Incentive Grants Program: Perceptions from residency program 评估APhA基金会奖励补助计划:来自住院医师计划的看法。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-13 DOI: 10.1016/j.japh.2026.103025
Emily Albers, Shanna K. O'Connor, Cristian Rodriquez

Background

The American Pharmacists Association (APhA) Foundation Incentive Grants Program provides financial support for practice-based research projects designed to enhance the health outcomes of patients. Incentive grants have been a staiting point for many pharmacists, residents, and students to develop a passion for innovative patient care.

Objective

To evaluate residency program directors' (RPDs) perception of the Incentive Grants Program, the perceived value of program facilitation, and impact of the program on practice sites.

Methods

RPDs from Incentive Grant-funded programs participated in a 16-item survey and follow-up focus groups where they responded to questions related to their programs, their residents, program-related publications, impact of the program, and perceptions of the program and experience.

Results

Twenty-five RPDs completed the survey and 9 participated in focus groups. Findings included that 95.7% of respondents agreed or strongly agreed that the Incentive Grants program is valuable to community-based practice, and agreement that residents benefit from Incentive Grants. Some areas of improvement for the Incentive Grants program were identified, including a need to refine the scoring rubric for applications to more heavily weigh feasibility, communication from APhA foundation coordinators to RPDs and residents, and expectations related to publications.

Conclusion

The Incentive Grants program is positively perceived by RPDs and can be improved by streamlining communication and administration of the program. The program-funded projects are valuable to community-based practice and the grants themselves may benefit trainees more than broadly impacting practice.
背景:美国药剂师协会(APhA)基金会激励资助计划为旨在提高患者健康结果的基于实践的研究项目提供财政支持。激励补助金已经成为许多药剂师、住院医生和学生培养创新病人护理热情的起点。目的:评估住院医师项目主任(rpd)对激励补助项目的感知、项目促进的感知价值以及项目对实习场所的影响。方法:来自激励基金资助项目的住院医师项目主任参与了一项16项调查和后续焦点小组,他们回答了与他们的项目、他们的住院医师、项目相关的出版物、项目的影响以及对项目和经验的看法有关的问题。结果:有25位RPDs完成了调查,9位参与了焦点小组。调查结果包括95.7%的受访者同意或强烈同意激励赠款计划对社区实践有价值,并同意居民从激励赠款中受益。奖励性资助计划的一些改进领域被确定,包括需要完善申请的评分标准,以更重地衡量可行性,APhA基金会协调员与rpd和居民的沟通,以及与出版物相关的期望。结论:rpd对激励补助计划有积极的看法,可以通过简化该计划的沟通和管理来改进。计划资助的项目对社区实践是有价值的,赠款本身可能使受训者受益,而不是广泛影响实践。
{"title":"Evaluating the APhA Foundation Incentive Grants Program: Perceptions from residency program","authors":"Emily Albers,&nbsp;Shanna K. O'Connor,&nbsp;Cristian Rodriquez","doi":"10.1016/j.japh.2026.103025","DOIUrl":"10.1016/j.japh.2026.103025","url":null,"abstract":"<div><h3>Background</h3><div>The American Pharmacists Association (APhA) Foundation Incentive Grants Program provides financial support for practice-based research projects designed to enhance the health outcomes of patients. Incentive grants have been a staiting point for many pharmacists, residents, and students to develop a passion for innovative patient care.</div></div><div><h3>Objective</h3><div>To evaluate residency program directors' (RPDs) perception of the Incentive Grants Program, the perceived value of program facilitation, and impact of the program on practice sites.</div></div><div><h3>Methods</h3><div>RPDs from Incentive Grant-funded programs participated in a 16-item survey and follow-up focus groups where they responded to questions related to their programs, their residents, program-related publications, impact of the program, and perceptions of the program and experience.</div></div><div><h3>Results</h3><div>Twenty-five RPDs completed the survey and 9 participated in focus groups. Findings included that 95.7% of respondents agreed or strongly agreed that the Incentive Grants program is valuable to community-based practice, and agreement that residents benefit from Incentive Grants. Some areas of improvement for the Incentive Grants program were identified, including a need to refine the scoring rubric for applications to more heavily weigh feasibility, communication from APhA foundation coordinators to RPDs and residents, and expectations related to publications.</div></div><div><h3>Conclusion</h3><div>The Incentive Grants program is positively perceived by RPDs and can be improved by streamlining communication and administration of the program. The program-funded projects are valuable to community-based practice and the grants themselves may benefit trainees more than broadly impacting practice.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 2","pages":"Article 103025"},"PeriodicalIF":2.5,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145992997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacist's role in addressing barriers to continuous glucose monitoring within underserved communities 药剂师在解决服务不足社区持续血糖监测障碍中的作用。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-05 DOI: 10.1016/j.japh.2025.103016
Christ Ange K. Cellino , En-Ling Chen , Julia Pawelek, Chris J. Daly, David M. Jacobs, Gina M. Prescott
Continuous glucose monitoring (CGM) has transformed diabetes care by enabling real-time tracking of glucose levels, improving glycemic control, reducing hypoglycemia, and enhancing quality of life. Despite their clinical benefits, CGM adoption remains inequitable, with underserved populations facing barriers such as low digital and health literacy, financial hardship, limited provider engagement, and fragmented healthcare system infrastructure. Pharmacists, trusted and accessible providers embedded within communities, have emerged as key collaborators for CGM use through patient education, data interpretation, and treatment optimization. Evidence from community-based settings demonstrates that pharmacist-led CGM interventions are associated with significant reductions in HbA1c, improvements in time-in-range, and enhanced patient engagement, although studies focusing specifically on underserved populations remain limited. Persistent barriers at patient, provider, and system levels must be addressed to achieve equitable CGM system access, including challenges related to cost, digital access or literacy, language barriers, health care professional training and patient education. By advancing pharmacist-led CGM initiatives tailored to the social and cultural needs of underserved populations, there is an opportunity to reduce disparities in CGM utilization and improve diabetes outcomes. This commentary highlights current evidence, identifies gaps, and issues a call to action for expanding pharmacist-led CGM programs in high need populations as a critical step toward promoting health equity in diabetes management.
连续血糖监测(CGM)通过实时跟踪血糖水平、改善血糖控制、减少低血糖和提高生活质量,改变了糖尿病护理。尽管有临床益处,但CGM的采用仍然不公平,服务不足的人群面临着诸如数字和健康素养低、经济困难、提供者参与有限以及医疗保健系统基础设施分散等障碍。药剂师是社区内可信赖和可接近的提供者,通过患者教育、数据解释和治疗优化,已成为CGM使用的关键合作者。来自社区环境的证据表明,药剂师主导的CGM干预与HbA1c的显著降低、范围时间的改善和患者参与度的提高有关,尽管专门针对服务不足人群的研究仍然有限。必须解决患者、提供者和系统层面的持续障碍,以实现公平的CGM系统访问,包括与成本、数字访问或扫盲、语言障碍、医疗保健专业培训和患者教育相关的挑战。通过推进药剂师主导的针对服务不足人群的社会和文化需求的CGM计划,有机会缩小CGM利用的差距并改善糖尿病结局。本评论强调了目前的证据,确定了差距,并呼吁采取行动,在高需求人群中扩大药剂师主导的CGM项目,作为促进糖尿病管理健康公平的关键一步。
{"title":"Pharmacist's role in addressing barriers to continuous glucose monitoring within underserved communities","authors":"Christ Ange K. Cellino ,&nbsp;En-Ling Chen ,&nbsp;Julia Pawelek,&nbsp;Chris J. Daly,&nbsp;David M. Jacobs,&nbsp;Gina M. Prescott","doi":"10.1016/j.japh.2025.103016","DOIUrl":"10.1016/j.japh.2025.103016","url":null,"abstract":"<div><div>Continuous glucose monitoring (CGM) has transformed diabetes care by enabling real-time tracking of glucose levels, improving glycemic control, reducing hypoglycemia, and enhancing quality of life. Despite their clinical benefits, CGM adoption remains inequitable, with underserved populations facing barriers such as low digital and health literacy, financial hardship, limited provider engagement, and fragmented healthcare system infrastructure. Pharmacists, trusted and accessible providers embedded within communities, have emerged as key collaborators for CGM use through patient education, data interpretation, and treatment optimization. Evidence from community-based settings demonstrates that pharmacist-led CGM interventions are associated with significant reductions in HbA1c, improvements in time-in-range, and enhanced patient engagement, although studies focusing specifically on underserved populations remain limited. Persistent barriers at patient, provider, and system levels must be addressed to achieve equitable CGM system access, including challenges related to cost, digital access or literacy, language barriers, health care professional training and patient education. By advancing pharmacist-led CGM initiatives tailored to the social and cultural needs of underserved populations, there is an opportunity to reduce disparities in CGM utilization and improve diabetes outcomes. This commentary highlights current evidence, identifies gaps, and issues a call to action for expanding pharmacist-led CGM programs in high need populations as a critical step toward promoting health equity in diabetes management.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 2","pages":"Article 103016"},"PeriodicalIF":2.5,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145919590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Telehealth-enabled pill swallowing training for a pediatric patient living with HIV: A multidisciplinary approach 为一名感染艾滋病毒的儿科患者提供远程保健药丸吞咽训练:一种多学科方法。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 DOI: 10.1016/j.japh.2025.103006
Timothy J. Howze, Susan D. Carr, Megan L. Wilkins, Tiffany M. Nason, Nehali D. Patel

Background

This case report aims to describe the implementation of a telehealth-based, multidisciplinary intervention designed to support pill swallowing in a pediatric patient with HIV preparing to transition from liquid to tablet-based antiretroviral therapy (ART). The objective was to overcome geographic and access-related barriers to in-person behavioral training by leveraging virtual care, interdisciplinary collaboration, and the use of compounded placebo tablets. This approach sought to demonstrate how specialty pharmacists and behavioral health professionals can work together to ensure medication readiness, promote adherence, and facilitate safe transitions to more sustainable ART regimens in pediatric patients—particularly those in rural or underserved settings.

Case summary

A pediatric patient with vertically acquired HIV who was residing in a rural community was preparing to transition from liquid ART to a fixed-dose combination tablet. Transportation barriers rendered in-person training infeasible. The care team, comprising a specialty pharmacist, clinical psychologist, and compounding pharmacy staff, designed a remote intervention. Placebo tablets matching the target medication were mailed to the patient's home. A telehealth session was conducted by using the Epic electronic medical record platform, and real-time, behavioral coaching and pharmacist-led guidance were provided. The patient successfully swallowed 2 placebo tablets during the telehealth session, indicating readiness for the transition. At the next clinic visit, the patient initiated the new fixed-dose combination ART without complications. Follow-up confirmed continued adherence to pill formulation and no reported adverse effects.

Practice implications

This case highlights the value of telehealth in overcoming pill swallowing training barriers in pediatric HIV care. Interdisciplinary collaboration, particularly involving specialty pharmacists and behavioral health providers, can provide equitable, patient-centered solutions for families in underserved areas. The use of compounded placebo tablets in virtual training represents a practical and scalable strategy to support medication transitions in pediatric populations.
目的:本病例报告旨在描述一种基于远程医疗的多学科干预措施的实施,旨在支持一名准备从液体抗逆转录病毒治疗过渡到片剂抗逆转录病毒治疗(ART)的儿科艾滋病毒患者吞咽药丸。目的是通过利用虚拟护理、跨学科合作和使用复合安慰剂片剂来克服地理和与现场行为训练相关的障碍。该方法旨在展示专业药剂师和行为健康专业人员如何共同努力,确保儿科患者的药物准备,促进依从性,并促进安全过渡到更可持续的抗逆转录病毒治疗方案,特别是在农村或服务不足的环境中。案例总结:一名居住在农村社区的垂直获得性艾滋病儿童患者正准备从液体抗逆转录病毒药物过渡到固定剂量的联合片剂。交通障碍使亲自培训变得不可行。护理小组由专业药剂师、临床心理学家和复合药房工作人员组成,设计了远程干预。与目标药物相匹配的安慰剂药片被邮寄到患者家中。利用Epic电子病历平台进行了远程医疗会议,并提供了实时行为指导和药剂师主导的指导。患者在远程医疗会议期间成功吞下了两片安慰剂片,表明已准备好过渡。在下一次门诊就诊时,患者开始了新的固定剂量联合抗逆转录病毒治疗,没有并发症。随访证实继续遵守药丸配方,无不良反应报告。实践意义:本病例强调了远程医疗在克服儿科艾滋病毒护理中药丸吞咽训练障碍方面的价值。跨学科合作,特别是涉及专业药剂师和行为保健提供者的合作,可以为服务不足地区的家庭提供公平的、以病人为中心的解决办法。在虚拟培训中使用复合安慰剂片代表了一种实用且可扩展的策略,以支持儿科人群的药物转换。
{"title":"Telehealth-enabled pill swallowing training for a pediatric patient living with HIV: A multidisciplinary approach","authors":"Timothy J. Howze,&nbsp;Susan D. Carr,&nbsp;Megan L. Wilkins,&nbsp;Tiffany M. Nason,&nbsp;Nehali D. Patel","doi":"10.1016/j.japh.2025.103006","DOIUrl":"10.1016/j.japh.2025.103006","url":null,"abstract":"<div><h3>Background</h3><div>This case report aims to describe the implementation of a telehealth-based, multidisciplinary intervention designed to support pill swallowing in a pediatric patient with HIV preparing to transition from liquid to tablet-based antiretroviral therapy (ART). The objective was to overcome geographic and access-related barriers to in-person behavioral training by leveraging virtual care, interdisciplinary collaboration, and the use of compounded placebo tablets. This approach sought to demonstrate how specialty pharmacists and behavioral health professionals can work together to ensure medication readiness, promote adherence, and facilitate safe transitions to more sustainable ART regimens in pediatric patients—particularly those in rural or underserved settings.</div></div><div><h3>Case summary</h3><div>A pediatric patient with vertically acquired HIV who was residing in a rural community was preparing to transition from liquid ART to a fixed-dose combination tablet. Transportation barriers rendered in-person training infeasible. The care team, comprising a specialty pharmacist, clinical psychologist, and compounding pharmacy staff, designed a remote intervention. Placebo tablets matching the target medication were mailed to the patient's home. A telehealth session was conducted by using the Epic electronic medical record platform, and real-time, behavioral coaching and pharmacist-led guidance were provided. The patient successfully swallowed 2 placebo tablets during the telehealth session, indicating readiness for the transition. At the next clinic visit, the patient initiated the new fixed-dose combination ART without complications. Follow-up confirmed continued adherence to pill formulation and no reported adverse effects.</div></div><div><h3>Practice implications</h3><div>This case highlights the value of telehealth in overcoming pill swallowing training barriers in pediatric HIV care. Interdisciplinary collaboration, particularly involving specialty pharmacists and behavioral health providers, can provide equitable, patient-centered solutions for families in underserved areas. The use of compounded placebo tablets in virtual training represents a practical and scalable strategy to support medication transitions in pediatric populations.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 103006"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145746494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mapping the U.S. literature on pharmacists prescribing to initiate medications: A scoping review of terminology, responsibilities, and alignment with international models 绘制美国关于药剂师开处方启动药物的文献:术语、责任和与国际模式的一致性的范围审查。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2026-01-01 DOI: 10.1016/j.japh.2025.102952
Surur Ahmed, Janice Kung, Vincent Chiang, Arjun Poudel, Damilola Olufemi-Yusuf, Chowdhury Farhana Faruquee, Mark Makowsky, Lisa Nissen, Lisa Guirguis

Background

Pharmacists play a greater role in patient-centred care, particularly in prescribing to initiate medications. In the United States, pharmacist prescribing evolved to meet healthcare challenges, although states vary in prescribing models, pharmacists' responsibilities, and terminology.
A literature review is necessary to capture and compare pharmacist practices in prescribing to initiate medications across the United States.

Objectives

This review aims to 1) characterize US prescribing terminology and pharmacists' responsibilities when initiating medication under various U.S. prescribing models, and 2) map the U.S. literature on pharmacists' initiating medication to the international context.

Methods

The study employed Arksey and O'Malley's scoping review framework and adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews. Ovid MEDLINE, Ovid Embase, and CINAHL were searched from 2000 to 2024. Eligible studies were included if they examined pharmacists initiating medication across diverse practice settings and prescribing models. Two independent reviewers conducted screening and data charting. The terminology and pharmacists' responsibilities when initiating medication (i.e., recognizing symptoms/diagnosis, selecting, supplying, and monitoring medications) under U.S. prescribing models were examined and categorized using international pharmacist prescribing models.

Results

Out of 92 studies, terminology describing pharmacist-initiated medication models varies widely, from formal legislative language to informal and broadly used descriptions. Most studies (n = 58) reported 3 of 4 pharmacist responsibilities, with diagnosing symptoms (n = 85) and selecting medication (n = 88) the most commonly reported. When using the international pharmacist prescribing models, prescribing by protocol (n = 77) was dominant, followed by independent prescribing in the Veterans Health Administration (n = 9) and formulary prescribing in Idaho state (n = 2).

Conclusion

This review has uniquely mapped the U.S. literature on pharmacists initiating medication to the international context, highlighting variation in prescribing terminology and responsibilities. The findings underscore the need for a standardized reporting guide with clear terminology and definitions of pharmacist prescribing responsibilities to facilitate meaningful international comparisons.
背景:药剂师在以患者为中心的护理中发挥着更大的作用,特别是在开处方开始用药方面。在美国,尽管各州在开处方模式、药剂师的职责和术语方面有所不同,但药剂师开处方的发展是为了应对医疗保健方面的挑战。文献综述是必要的,以捕获和比较药剂师的做法,在处方启动药物在美国。目的:本综述旨在:1)描述美国不同处方模式下的处方术语和药剂师在开药时的责任;2)将美国关于药剂师开药的文献与国际背景进行对比。方法:本研究采用Arksey和O'Malley的范围评价框架,并遵循PRISMA-ScR指南。检索了2000年至2024年的Ovid MEDLINE、Ovid Embase和CINAHL。如果他们检查药剂师在不同的实践环境和处方模式下开始用药,则纳入符合条件的研究。两名独立审稿人进行了筛选和数据制图。在美国处方模式下,术语和药剂师在开始用药时的责任(即识别症状/诊断、选择、供应和监测药物)被检查并使用国际药剂师处方模型进行分类。结果:在92项研究中,描述药剂师发起的药物模型的术语差异很大,从正式的立法语言到非正式的和广泛使用的描述。大多数研究(n = 58)报告了四项药剂师职责中的三项,其中诊断症状(n = 85)和选择药物(n = 88)是最常见的。使用国际药师处方模型时,以方案处方为主(n = 77),其次是退伍军人健康管理局的独立处方(n = 9)和爱达荷州的处方处方(n = 2)。结论:本综述独特地将美国关于药剂师开始用药的文献映射到国际背景下,突出了处方术语和责任的变化。研究结果强调需要一个标准化的报告指南,其中包括明确的术语和药剂师开处方责任的定义,以促进有意义的国际比较。
{"title":"Mapping the U.S. literature on pharmacists prescribing to initiate medications: A scoping review of terminology, responsibilities, and alignment with international models","authors":"Surur Ahmed,&nbsp;Janice Kung,&nbsp;Vincent Chiang,&nbsp;Arjun Poudel,&nbsp;Damilola Olufemi-Yusuf,&nbsp;Chowdhury Farhana Faruquee,&nbsp;Mark Makowsky,&nbsp;Lisa Nissen,&nbsp;Lisa Guirguis","doi":"10.1016/j.japh.2025.102952","DOIUrl":"10.1016/j.japh.2025.102952","url":null,"abstract":"<div><h3>Background</h3><div>Pharmacists play a greater role in patient-centred care, particularly in prescribing to initiate medications. In the United States, pharmacist prescribing evolved to meet healthcare challenges, although states vary in prescribing models, pharmacists' responsibilities, and terminology.</div><div>A literature review is necessary to capture and compare pharmacist practices in prescribing to initiate medications across the United States.</div></div><div><h3>Objectives</h3><div>This review aims to 1) characterize US prescribing terminology and pharmacists' responsibilities when initiating medication under various U.S. prescribing models, and 2) map the U.S. literature on pharmacists' initiating medication to the international context.</div></div><div><h3>Methods</h3><div>The study employed Arksey and O'Malley's scoping review framework and adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews. Ovid MEDLINE, Ovid Embase, and CINAHL were searched from 2000 to 2024. Eligible studies were included if they examined pharmacists initiating medication across diverse practice settings and prescribing models. Two independent reviewers conducted screening and data charting. The terminology and pharmacists' responsibilities when initiating medication (i.e., recognizing symptoms/diagnosis, selecting, supplying, and monitoring medications) under U.S. prescribing models were examined and categorized using international pharmacist prescribing models.</div></div><div><h3>Results</h3><div>Out of 92 studies, terminology describing pharmacist-initiated medication models varies widely, from formal legislative language to informal and broadly used descriptions. Most studies (n = 58) reported 3 of 4 pharmacist responsibilities, with diagnosing symptoms (n = 85) and selecting medication (n = 88) the most commonly reported. When using the international pharmacist prescribing models, prescribing by protocol (n = 77) was dominant, followed by independent prescribing in the Veterans Health Administration (n = 9) and formulary prescribing in Idaho state (n = 2).</div></div><div><h3>Conclusion</h3><div>This review has uniquely mapped the U.S. literature on pharmacists initiating medication to the international context, highlighting variation in prescribing terminology and responsibilities. The findings underscore the need for a standardized reporting guide with clear terminology and definitions of pharmacist prescribing responsibilities to facilitate meaningful international comparisons.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 1","pages":"Article 102952"},"PeriodicalIF":2.5,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145338440","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Disparity implications of machine-learning-based MTM eligibility criteria 基于机器学习的MTM资格标准的差异含义。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-30 DOI: 10.1016/j.japh.2025.103015
Chi Chun Steve Tsang, Yan Cui, William C. Cushman, Catherine M. Crill, Katherine Stracner, Junling Wang

Background

Although Medicare Medication Therapy Management (MTM) programs have demonstrated clinical and economic benefits, racial/ethnic minority groups face challenges meeting eligibility criteria for enrollment. In 2017, the Centers for Medicare and Medicaid Services launched the 5-year Enhanced MTM demonstration, granting Part D plans flexibility in identifying eligible beneficiaries. However, because participating plans adopted predictive modeling to determine eligibility, concerns persist that this approach may perpetuate existing racial/ethnic disparities.

Objectives

To assess whether health cost-based MTM eligibility differs across race/ethnicity and whether machine learning models reproduce observed disparities in predicted eligibility.

Methods

This study analyzed 2019 Medicare administrative data linked to the Area Health Resource File for a 10% random sample of fee-for-service beneficiaries. Outcomes were binary indicators of top-quartile medication and health care costs, each measured from the Medicare and health care system perspectives. Multivariable logistic regression was employed to assess racial/ethnic disparities in top-quartile costs, using 6 algorithms – regularized logistic regression, random forest, gradient boosted trees, support vector machine, multilayer perceptron, and a consensus model. Predicted probabilities were computed to assess disparities in model outputs using multivariable fractional logistic regression.

Results

Among 1,848,654 Medicare beneficiaries, Black and Hispanic individuals had significantly lower adjusted odds of top-quartile costs across all cost outcomes compared to their non-Hispanic White counterparts. For instance, the odds of being in the top quartile for total medication costs were 28% lower for Black beneficiaries (odds ratio [OR] = 0.72, 95% confidence interval [CI] = 0.70–0.75) and 21% lower for Hispanic beneficiaries (OR = 0.79, 95% CI = 0.74–0.84). Machine learning models reproduced these disparities in predicted probabilities, mirroring patterns in the empirical data.

Conclusion

Implementing cost-based MTM eligibility through predictive algorithms may perpetuate racial/ethnic disparities in MTM program access. Future research should explore strategies to mitigate such a potential when using such modeling to determine MTM eligibility.
背景:虽然医疗保险药物治疗管理(MTM)项目已经证明了临床和经济效益,但种族/少数民族群体面临着满足入组资格标准的挑战。2017年,医疗保险和医疗补助服务中心启动了为期5年的强化MTM示范,赋予D部分计划在确定合格受益人方面的灵活性。然而,由于参与计划采用预测模型来确定资格,人们仍然担心这种方法可能会使现有的种族/民族差异永续存在。目的:评估基于健康成本的MTM资格是否因种族/民族而异,以及机器学习模型是否再现了预测资格中观察到的差异。方法:本研究分析了与地区卫生资源文件相关的2019年医疗保险管理数据,随机抽取10%的付费服务受益人样本。结果是前四分位数药物和医疗保健费用的二元指标,每个指标都是从医疗保险和医疗保健系统的角度来衡量的。采用多变量逻辑回归来评估种族/民族在前四分位数成本上的差异,使用六种算法-正则化逻辑回归,随机森林,梯度增强树,支持向量机,多层感知器和共识模型。使用多变量分数逻辑回归计算预测概率以评估模型输出的差异。结果:在1848654名医疗保险受益人中,与非西班牙裔白人相比,黑人和西班牙裔个体在所有成本结果中获得前四分位数成本的调整几率显著降低。例如,黑人受益人在总药物费用中处于前四分位数的几率低28%(比值比[OR]=0.72, 95%可信区间[CI]=0.70-0.75),西班牙裔受益人低21% (OR=0.79, 95% CI=0.74-0.84)。机器学习模型在预测概率中再现了这些差异,反映了经验数据中的模式。结论:通过预测算法实施基于成本的MTM资格可能会使MTM计划获得中的种族/民族差异永续存在。未来的研究应该探索在使用这种建模来确定MTM资格时减轻这种潜力的策略。
{"title":"Disparity implications of machine-learning-based MTM eligibility criteria","authors":"Chi Chun Steve Tsang,&nbsp;Yan Cui,&nbsp;William C. Cushman,&nbsp;Catherine M. Crill,&nbsp;Katherine Stracner,&nbsp;Junling Wang","doi":"10.1016/j.japh.2025.103015","DOIUrl":"10.1016/j.japh.2025.103015","url":null,"abstract":"<div><h3>Background</h3><div>Although Medicare Medication Therapy Management (MTM) programs have demonstrated clinical and economic benefits, racial/ethnic minority groups face challenges meeting eligibility criteria for enrollment. In 2017, the Centers for Medicare and Medicaid Services launched the 5-year Enhanced MTM demonstration, granting Part D plans flexibility in identifying eligible beneficiaries. However, because participating plans adopted predictive modeling to determine eligibility, concerns persist that this approach may perpetuate existing racial/ethnic disparities.</div></div><div><h3>Objectives</h3><div>To assess whether health cost-based MTM eligibility differs across race/ethnicity and whether machine learning models reproduce observed disparities in predicted eligibility.</div></div><div><h3>Methods</h3><div>This study analyzed 2019 Medicare administrative data linked to the Area Health Resource File for a 10% random sample of fee-for-service beneficiaries. Outcomes were binary indicators of top-quartile medication and health care costs, each measured from the Medicare and health care system perspectives. Multivariable logistic regression was employed to assess racial/ethnic disparities in top-quartile costs, using 6 algorithms – regularized logistic regression, random forest, gradient boosted trees, support vector machine, multilayer perceptron, and a consensus model. Predicted probabilities were computed to assess disparities in model outputs using multivariable fractional logistic regression.</div></div><div><h3>Results</h3><div>Among 1,848,654 Medicare beneficiaries, Black and Hispanic individuals had significantly lower adjusted odds of top-quartile costs across all cost outcomes compared to their non-Hispanic White counterparts. For instance, the odds of being in the top quartile for total medication costs were 28% lower for Black beneficiaries (odds ratio [OR] = 0.72, 95% confidence interval [CI] = 0.70–0.75) and 21% lower for Hispanic beneficiaries (OR = 0.79, 95% CI = 0.74–0.84). Machine learning models reproduced these disparities in predicted probabilities, mirroring patterns in the empirical data.</div></div><div><h3>Conclusion</h3><div>Implementing cost-based MTM eligibility through predictive algorithms may perpetuate racial/ethnic disparities in MTM program access. Future research should explore strategies to mitigate such a potential when using such modeling to determine MTM eligibility.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 2","pages":"Article 103015"},"PeriodicalIF":2.5,"publicationDate":"2025-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145890920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How individuals choose medications: Tool development for a discrete choice experiment on eye allergy treatment decisions 个人如何选择药物:一个关于眼睛过敏治疗决策的离散选择实验的工具开发。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-24 DOI: 10.1016/j.japh.2025.103010
Laura Formosa, Ruben Vargas, Leslie Wilson

Background

Allergic conjunctivitis affects nearly 40% of the U.S. population, triggered by allergens like pollen or pet dander. Since only 10% of individuals seek medical attention, most rely on over-the-counter (OTC) treatments. The condition can be managed with OTC and prescription (Rx) medications, depending on symptom severity. However, little is known about how individuals decide between treatment approaches.

Objectives

This study aimed to develop and pilot-test a choice-based conjoint (CBC) tool to measure preferences for 3 treatment approaches: 1) self-selected OTC treatment, 2) pharmacist-advised OTC treatment, and 3) physician-prescribed Rx treatment.

Methods

We developed a CBC tool following ISPOR guidelines for conjoint analysis and discrete choice experiments. Key steps included identifying relevant attributes through literature review, validating them through interviews (n = 9), and designing the CBC in Sawtooth Software (Sawtooth Software, Inc) with 10 random and 3 fixed scenarios. Validity testing was conducted with 22 participants to evaluate the tool's ability to capture variability across preference responses.

Results

The CBC tool included 7 attributes: speed of access to treatment, first treatment decision, accuracy of treatment, ease and comfort of administration, cost, time and duration of relief, and side effects, each with 2–3 levels. Validity results showed capture of variability in responses and ability to respond to fixed questions.

Conclusion

This research developed a CBC tool using discrete choice methods to measure how individuals make trade-offs among access, symptom relief, and other factors when selecting treatment approaches for allergic conjunctivitis. The tool offers a replicable framework for measuring individual's treatment management decisions in health care across the health care continuum. This tool will allow measurement of individual preferences for medication choices across the spectrum from self- or pharmacy-assisted OTC, to physician prescribed treatments.
背景:过敏性结膜炎影响了近40%的美国人口,由花粉或宠物皮屑等过敏原引发。由于只有10%的人寻求医疗护理,大多数人依赖于非处方(OTC)治疗。这种情况可以根据症状的严重程度用OTC和处方药物治疗。然而,人们对个体如何选择不同的治疗方法知之甚少。目的:本研究旨在开发和试点测试一个基于选择的联合(CBC)工具来衡量三种治疗方法的偏好:1)自我选择的OTC治疗,2)药剂师建议的OTC治疗,3)医生开处方的Rx治疗。方法:我们根据ISPOR指南开发了CBC工具,用于联合分析和离散选择实验(dce)。关键步骤包括通过文献综述识别相关属性,通过访谈(n=9)进行验证,并在Sawtooth Software中设计CBC,包含10个随机场景和3个固定场景。对22名参与者进行了有效性测试,以评估该工具在偏好反应中捕捉可变性的能力。结果:CBC工具包括7个属性:获得治疗的速度、首次治疗决策、治疗的准确性、给药的易用性和舒适性、成本、缓解时间和持续时间、副作用,每个属性为2-3个级别。效度结果显示了反应的可变性和对固定问题的反应能力。结论:本研究开发了一种CBC工具,使用离散选择方法来衡量个体在选择过敏性结膜炎治疗方法时如何在可及性、症状缓解和其他因素之间进行权衡。该工具提供了一个可复制的框架,用于衡量整个医疗保健连续体中个人的治疗管理决策。该工具将允许测量个人对药物选择的偏好,从自我或药物辅助的OTC到医生处方治疗。
{"title":"How individuals choose medications: Tool development for a discrete choice experiment on eye allergy treatment decisions","authors":"Laura Formosa,&nbsp;Ruben Vargas,&nbsp;Leslie Wilson","doi":"10.1016/j.japh.2025.103010","DOIUrl":"10.1016/j.japh.2025.103010","url":null,"abstract":"<div><h3>Background</h3><div>Allergic conjunctivitis affects nearly 40% of the U.S. population, triggered by allergens like pollen or pet dander. Since only 10% of individuals seek medical attention, most rely on over-the-counter (OTC) treatments. The condition can be managed with OTC and prescription (Rx) medications, depending on symptom severity. However, little is known about how individuals decide between treatment approaches.</div></div><div><h3>Objectives</h3><div>This study aimed to develop and pilot-test a choice-based conjoint (CBC) tool to measure preferences for 3 treatment approaches: 1) self-selected OTC treatment, 2) pharmacist-advised OTC treatment, and 3) physician-prescribed Rx treatment.</div></div><div><h3>Methods</h3><div>We developed a CBC tool following ISPOR guidelines for conjoint analysis and discrete choice experiments. Key steps included identifying relevant attributes through literature review, validating them through interviews (n = 9), and designing the CBC in Sawtooth Software (Sawtooth Software, Inc) with 10 random and 3 fixed scenarios. Validity testing was conducted with 22 participants to evaluate the tool's ability to capture variability across preference responses.</div></div><div><h3>Results</h3><div>The CBC tool included 7 attributes: speed of access to treatment, first treatment decision, accuracy of treatment, ease and comfort of administration, cost, time and duration of relief, and side effects, each with 2–3 levels. Validity results showed capture of variability in responses and ability to respond to fixed questions.</div></div><div><h3>Conclusion</h3><div>This research developed a CBC tool using discrete choice methods to measure how individuals make trade-offs among access, symptom relief, and other factors when selecting treatment approaches for allergic conjunctivitis. The tool offers a replicable framework for measuring individual's treatment management decisions in health care across the health care continuum. This tool will allow measurement of individual preferences for medication choices across the spectrum from self- or pharmacy-assisted OTC, to physician prescribed treatments.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 2","pages":"Article 103010"},"PeriodicalIF":2.5,"publicationDate":"2025-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145844661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacists' propensity to trust automated technologies: A demographic analysis 药剂师信任自动化技术的倾向:人口统计学分析。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-23 DOI: 10.1016/j.japh.2025.103011
Megan Whitaker, Brigid Rowell, Jin Yong Kim, Raed Al Kontar, X. Jessie Yang, Corey A. Lester

Background

Artificial intelligence (AI), in conjunction with automated technologies, is being deployed in pharmacies. Little research has been published regarding pharmacists' general willingness to trust AI. Understanding pharmacists' propensity to trust (PTT) AI may help guide the successful implementation and adoption of AI tools.

Objective

The objective is to assess pharmacists' PTT AI with automated technology and identify factors that may influence this tendency.

Methods

As part of a larger study, licensed pharmacists completed a demographics survey and the PTT survey before testing AI advice on medication fills. The PTT survey consisted of 6 statements about AI and pharmacists indicated their level of agreement using a 5-point Likert scale, with higher numbers indicating more agreement. Summary statistics, Kruskal-Wallis tests, linear regressions, and confidence intervals were calculated.

Results

Ninety-nine pharmacists completed the surveys. The mean pharmacist age was 38.1 years and the median PTT score was 3.83 (P < 0.001). Age was a statistically significant predictor of PTT (β = 0.02, P < 0.001, and R2 = 0.11). Linear regressions yielded statistically significant results for age and the work experience category of 21 or more years. No significant differences were found between the PTT scores and gender, ethnicity, race, or pharmacy setting.

Conclusions

Older and more experienced pharmacists had higher PTT scores. Exposure to AI tools during pharmacy education may help younger pharmacists optimize their PTT AI.
背景:人工智能(AI)与自动化技术正在药房中得到应用。关于药剂师普遍愿意信任人工智能的研究很少发表。了解药剂师信任人工智能的倾向可能有助于指导人工智能工具的成功实施和采用。目的:目的是评估药剂师信任人工智能与自动化技术的倾向,并确定可能影响这种倾向的因素。方法:作为一项更大规模研究的一部分,在测试人工智能对药物填充物的建议之前,有执照的药剂师完成了一项人口统计调查和信任倾向(PTT)调查。PTT调查包括6个关于人工智能的陈述,药剂师使用5分李克特量表表示他们的同意程度,数字越高表示同意程度越高。计算了汇总统计、Kruskal-Wallis检验、线性回归和置信区间。结果:共有99名药师完成调查。药师平均年龄38.1岁,PTT评分中位数为3.83分(p 2 = 0.11)。线性回归对年龄和21年以上工作经验类别产生了统计上显著的结果。PTT评分与性别、民族、种族或药房设置之间无显著差异。结论:药师年龄越大,经验越丰富,PTT评分越高。在药学教育期间接触人工智能工具可能有助于年轻药剂师优化他们对人工智能的信任倾向。
{"title":"Pharmacists' propensity to trust automated technologies: A demographic analysis","authors":"Megan Whitaker,&nbsp;Brigid Rowell,&nbsp;Jin Yong Kim,&nbsp;Raed Al Kontar,&nbsp;X. Jessie Yang,&nbsp;Corey A. Lester","doi":"10.1016/j.japh.2025.103011","DOIUrl":"10.1016/j.japh.2025.103011","url":null,"abstract":"<div><h3>Background</h3><div>Artificial intelligence (AI), in conjunction with automated technologies, is being deployed in pharmacies. Little research has been published regarding pharmacists' general willingness to trust AI. Understanding pharmacists' propensity to trust (PTT) AI may help guide the successful implementation and adoption of AI tools.</div></div><div><h3>Objective</h3><div>The objective is to assess pharmacists' PTT AI with automated technology and identify factors that may influence this tendency.</div></div><div><h3>Methods</h3><div>As part of a larger study, licensed pharmacists completed a demographics survey and the PTT survey before testing AI advice on medication fills. The PTT survey consisted of 6 statements about AI and pharmacists indicated their level of agreement using a 5-point Likert scale, with higher numbers indicating more agreement. Summary statistics, Kruskal-Wallis tests, linear regressions, and confidence intervals were calculated.</div></div><div><h3>Results</h3><div>Ninety-nine pharmacists completed the surveys. The mean pharmacist age was 38.1 years and the median PTT score was 3.83 (<em>P</em> &lt; 0.001). Age was a statistically significant predictor of PTT (β = 0.02, <em>P</em> &lt; 0.001, and R<sup>2</sup> = 0.11). Linear regressions yielded statistically significant results for age and the work experience category of 21 or more years. No significant differences were found between the PTT scores and gender, ethnicity, race, or pharmacy setting.</div></div><div><h3>Conclusions</h3><div>Older and more experienced pharmacists had higher PTT scores. Exposure to AI tools during pharmacy education may help younger pharmacists optimize their PTT AI.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 2","pages":"Article 103011"},"PeriodicalIF":2.5,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A unifying vision for pharmacy: Defining professional identity through stakeholder perspectives 药剂学的统一愿景:从利益相关者的角度定义职业身份。
IF 2.5 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pub Date : 2025-12-23 DOI: 10.1016/j.japh.2025.103013
Denise H. Rhoney, Kimberly K. Daugherty, Aleda M.H. Chen, Mariann Churchwell, Stephanie Sibicky, Krisy-Ann Thornby, Nicholas R. Nelson, Erika L. Kleppinger, Dennis Parker, Kelly R. Ragucci, Cindy D. Stowe PharmD, Tina P. Brock

Background

Amid evolving health care demands, pharmacy faces a critical identity inflection point that requires a cohesive vision.

Objective

This study aimed to define a cohesive, stakeholder-informed vision for the U.S. pharmacist's societal role by analyzing perceptions from across education, practice, and policy.

Methods

The study applied a multimethod qualitative design guided by constructivist epistemology incorporating thematic analysis, metaphor discourse analysis, force field mapping, and analysis of alignment with national forecast reports. Data were collected from 27 focus groups and 8 individual interviews with 148 participants representing 8 stakeholder categories.

Results

From these themes, five metaphorical roles emerged, medication safety and optimization; access and equity in health care; chronic disease management; health promotion and preventative services; and patient education, counseling, and advocacy, highlighting broad agreement on pharmacists' contributions. Five metaphorical roles, safety net, steward, coach, navigator, and advocate, reflected a multidimensional professional identity. Force field analysis demonstrated a balance between driving forces, such as accessibility, medication safety, and public health leadership, and restraining forces, including lack of provider status, regulatory variation, and workforce instability. Comparative analysis showed strong alignment with national pharmacy forecasts, though gaps emerged in areas such as digital readiness, economic literacy, and global practice models.

Conclusion

This study provides an empirically grounded framework to inform a unifying vision for pharmacy's future. Stakeholder insights reinforce the need for education reform, policy realignment, and narrative clarity to reposition pharmacists as essential contributors to health-system transformation. By embracing a hybrid identity and dismantling structural barriers, the profession can fulfill its societal mandate in safety, accessibility, and care innovation.
背景:在不断发展的医疗保健需求中,药房面临着一个关键的身份拐点,需要一个有凝聚力的愿景。目的:本研究旨在通过分析来自教育、实践和政策的看法,为美国药剂师的社会角色定义一个有凝聚力的、利益相关者知情的愿景。方法:采用建构主义认识论指导下的多方法定性设计,结合主题分析、隐喻话语分析、力场映射和与国家预测报告的一致性分析。数据收集自27个焦点小组和8个个人访谈,148名参与者代表8个利益相关者类别。结果:出现6个趋同主题:用药安全与优化;卫生保健的可及性和公平性;慢性病管理;促进健康和预防服务;以及患者教育、咨询和宣传,强调了对药剂师贡献的广泛认同。五个隐喻的角色,安全网,管家,教练,领航员和倡导者,反映了一个多维的职业身份。力场分析显示了驱动力(如可及性、药物安全和公共卫生领导)和约束力(包括缺乏提供者地位、监管变化和劳动力不稳定)之间的平衡。对比分析显示,与国家药房预测高度一致,但在数字化准备程度、经济素养和全球实践模型等领域出现了差距。结论:本研究提供了一个基于经验的框架,为药学的未来提供了一个统一的愿景。利益攸关方的见解加强了教育改革、政策调整和叙事清晰的必要性,从而将药剂师重新定位为卫生系统转型的重要贡献者。通过拥抱混合身份和拆除结构性障碍,该职业可以在安全、可及性和护理创新方面履行其社会使命。
{"title":"A unifying vision for pharmacy: Defining professional identity through stakeholder perspectives","authors":"Denise H. Rhoney,&nbsp;Kimberly K. Daugherty,&nbsp;Aleda M.H. Chen,&nbsp;Mariann Churchwell,&nbsp;Stephanie Sibicky,&nbsp;Krisy-Ann Thornby,&nbsp;Nicholas R. Nelson,&nbsp;Erika L. Kleppinger,&nbsp;Dennis Parker,&nbsp;Kelly R. Ragucci,&nbsp;Cindy D. Stowe PharmD,&nbsp;Tina P. Brock","doi":"10.1016/j.japh.2025.103013","DOIUrl":"10.1016/j.japh.2025.103013","url":null,"abstract":"<div><h3>Background</h3><div>Amid evolving health care demands, pharmacy faces a critical identity inflection point that requires a cohesive vision.</div></div><div><h3>Objective</h3><div>This study aimed to define a cohesive, stakeholder-informed vision for the U.S. pharmacist's societal role by analyzing perceptions from across education, practice, and policy.</div></div><div><h3>Methods</h3><div>The study applied a multimethod qualitative design guided by constructivist epistemology incorporating thematic analysis, metaphor discourse analysis, force field mapping, and analysis of alignment with national forecast reports. Data were collected from 27 focus groups and 8 individual interviews with 148 participants representing 8 stakeholder categories.</div></div><div><h3>Results</h3><div>From these themes, five metaphorical roles emerged, medication safety and optimization; access and equity in health care; chronic disease management; health promotion and preventative services; and patient education, counseling, and advocacy, highlighting broad agreement on pharmacists' contributions. Five metaphorical roles, safety net, steward, coach, navigator, and advocate, reflected a multidimensional professional identity. Force field analysis demonstrated a balance between driving forces, such as accessibility, medication safety, and public health leadership, and restraining forces, including lack of provider status, regulatory variation, and workforce instability. Comparative analysis showed strong alignment with national pharmacy forecasts, though gaps emerged in areas such as digital readiness, economic literacy, and global practice models.</div></div><div><h3>Conclusion</h3><div>This study provides an empirically grounded framework to inform a unifying vision for pharmacy's future. Stakeholder insights reinforce the need for education reform, policy realignment, and narrative clarity to reposition pharmacists as essential contributors to health-system transformation. By embracing a hybrid identity and dismantling structural barriers, the profession can fulfill its societal mandate in safety, accessibility, and care innovation.</div></div>","PeriodicalId":50015,"journal":{"name":"Journal of the American Pharmacists Association","volume":"66 2","pages":"Article 103013"},"PeriodicalIF":2.5,"publicationDate":"2025-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145835819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the American Pharmacists Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1